Cerevel Therapeutics Holdings Total Non Current Liabilities 2011-2026 | CERE

Annual Total Non Current Liabilities Cerevel Therapeutics Holdings

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	4.4 M	4.28 M	3.82 M	344 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
4.4 M	344 K	3.21 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Adagene ADAG	158 M	$ 1.65	7.91 %	$ 92.9 M	China
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.59	1.99 %	$ 8.64 B	Australia
Arrowhead Pharmaceuticals ARWR	686 M	$ 66.05	2.3 %	$ 8.83 B	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.52	-16.3 %	$ 388 M	Britain
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Biogen BIIB	9.03 B	$ 184.48	-1.67 %	$ 26.9 B	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
BioNTech SE BNTX	341 M	$ 102.17	2.32 %	$ 27.2 B	Germany
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
AstraZeneca PLC AZN	30.8 B	$ 93.52	-1.2 %	$ 96.9 B	Britain
Can-Fite BioPharma Ltd. CANF	1.63 M	$ 4.25	1.67 %	$ 9.25 B	Israel
BeiGene, Ltd. BGNE	374 M	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	48 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
Bristol-Myers Squibb Company BMY	59.9 B	$ 55.71	-0.28 %	$ 113 B	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Ascendis Pharma A/S ASND	101 M	$ 207.49	2.22 %	$ 5 B	Danmark
Codiak BioSciences CDAK	119 M	-	-55.98 %	$ 2.15 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Zai Lab Limited ZLAB	13.9 M	$ 18.37	-0.97 %	$ 18.2 B	China
Coherus BioSciences CHRS	189 M	$ 1.61	-5.03 %	$ 152 M	USA
Catalyst Biosciences CBIO	981 K	$ 10.84	0.46 %	$ 714 M	USA
Caladrius Biosciences CLBS	254 K	-	-16.75 %	$ 25.8 M	USA
Celldex Therapeutics CLDX	17.3 M	$ 25.59	-6.54 %	$ 1.65 M	USA
Cellectis S.A. CLLS	109 M	$ 4.22	-4.2 %	$ 116 M	France
Clearside Biomedical CLSD	4.72 M	-	-	$ 25.3 M	USA
Chimerix CMRX	196 K	-	-	$ 756 M	USA
Adaptimmune Therapeutics plc ADAP	23.6 M	-	-15.15 %	$ 60.3 M	Britain
Corcept Therapeutics Incorporated CORT	2.29 M	$ 37.35	-0.4 %	$ 3.86 B	USA
Catalyst Pharmaceuticals CPRX	648 K	$ 23.18	2.02 %	$ 2.75 B	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Crinetics Pharmaceuticals CRNX	4.9 M	$ 55.11	3.49 %	$ 4.45 B	USA
CRISPR Therapeutics AG CRSP	70.2 M	$ 55.17	2.47 %	$ 4.65 B	Schweiz
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Zentalis Pharmaceuticals ZNTL	4.16 M	$ 3.53	-5.75 %	$ 231 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	69.4 M	$ 29.43	6.09 %	$ 1.43 B	USA